DoD Breast Cancer Idea Award

The summary for the DoD Breast Cancer Idea Award Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	DoD Breast Cancer Idea Award
	CFDA Number:	12.420
	CFDA Description:	Military Medical Research and Development
	Federal Agency Name:	Dept of the Army USAMRAA
	Category of Funding Activity:	Science and Technology
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	W81XWH-11-BCRP-IDEA
	Document Type:	Grants Notice
	Funding Instrument Type:	Cooperative Agreement Grant
	Posted Date:	Apr 19, 2011
	Creation Date:	Apr 19, 2011
	Original Closing Date for Applications:	Aug 25, 2011
	Current Closing Date for Applications:	Aug 25, 2011
	Archive Date:	Sep 24, 2011
	Expected Number of Awards:	10
	Estimated Total Program Funding:	7,500,000
	Federal Grant Award Ceiling:	Information not provided
	Federal Grant Award Floor:	Information not provided
	Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Additional Information on Eligibility: Information not provided
Grant Description: The BCRP Idea Award mechanism has been revised for FY11. The Idea Award is designed to support promising research that has extraordinary potential to yield highly impactful data and new avenues of investigation. This mechanism supports innovative research that could ultimately lead to critical discoveries or major advancements that will accelerate the eradication of breast cancer. Although groundbreaking research often involves a degree of risk, applications should include a well-formulated, testable hypothesis based on strong scientific rationale. Impact and Innovation are the most important aspects of the Idea Award; however, applications that have the potential for high impact, but are not considered innovative, will also meet the intent of this award mechanism. Preliminary data is allowed, but not required. Impact: Research that has high potential impact may lead to major advancements and significantly accelerate the eradication of breast cancer. Innovation: Research deemed conceptually innovative may introduce a new paradigm, challenge current paradigms, look at existing problems from new perspectives, or exhibit other uniquely creative qualities. It is the responsibility of the Principal Investigator (PI) to explicitly articulate the projects potential impact on breast cancer and how the project is innovative. Partnering PI Option: The Idea Award mechanism encourages applications that include meaningful and productive collaborations between investigators. The Partnering PI Option under the Idea Award mechanism is structured to accommodate two PIs, with each under a separate award. The Initiating and Partnering PIs have different submission requirements; however, both PIs should contribute to the preparation of a single application. The collaborative partners may have expertise in similar or disparate scientific disciplines, but each partner is expected to bring different strengths to the application. New collaborations are encouraged, but not required. It is the responsibility of the collaborating investigators to describe how their combined expertise in the collaboration will better address the research question and explain why the work should be done together rather than through separate efforts. Applications submitted by a mentor and postdoctoral trainee as Initiating and Partnering PIs do not meet the intent of the Partnering PI Option.
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil eReceipt HELP: 301-682-5507; help@cdmrp.org
CDMRP Help Desk [cdmrp.pa@amedd.army.mil]
Similar Government Grants: • DOD FY11 Breast Cancer Research Program Clinical Translational Research Award; • DoD Peer Reviewed Orthopaedic Technology Development Award; • DoD Peer Reviewed Orthopaedic Translational Research Partnership Award; • DoD Peer Reviewed Orthopaedic Clinical Trial Award; • DoD Post-Traumatic Stress Disorder In-Home Therapy Clinical Trial Award; • FY2006 Deployed War Fighter Protection Research Program; • Department of Defense (DOD) Fiscal Year 2003 (FY03) Breast Cancer Research Program (BCRP)Concept Awa...; • Department of Defense (DOD) Fiscal Year 2004 (FY04) Breast Cancer Research Program (BCRP) Innovator ...; • Department of Defense (DOD) FY04 Breast Cancer Research Program (BCRP) Concept Award (CA); • Department of Defense Fiscal Year 2004 Breast Cancer Center of Excellence Award (COE)